This Week in Psychedelics - 10.2.20

ThisWeekinPsychedelics.png

Cannabis

  • FBI: Marijuana Arrests Decline Year-Over-Year, But Still Outpace Arrests for All Violent Crimes (NORML)

  • Colorado Governor Grants Thousands Of Marijuana Pardons With New Clemency Powers (Marijuana Moment)

  • New Jersey: Lawmakers Approve Telemedicine for Medical Cannabis Authorizations (NORML)

  • Hawaii: Governor Legalizes Sales of Edible Products by Licensed Medical Cannabis Dispensaries (NORML)

  • Democrats Remove Marijuana Research Bill From House Floor Schedule After Briefly Listing Possible Vote (Marijuana Moment)

  • Michigan: Lawmakers Approve Marijuana Expungement Legislation (NORML)

  • Where President Donald Trump Stands On Marijuana (Marijuana Moment)

  • New Jersey: Voter Support Solidly in Favor of Marijuana Legalization Ahead of Ballot Initiative Vote (NORML)

  • Study: Nearly Thirty Percent of Women Report Having Used Cannabis for Menopause Symptoms (NORML)

LSD

Magic Mushrooms

  • Oregon Psilocybin Initiative Gets Boost From New TV Ad But Draws Opposition From Unlikely Source (Marijuana Moment)

  • Psygen Labs To Supply NeonMind With Psilocybin For Weight Loss Study (Green Market Report)

  • Denver Mushroom Dealer Pleads Guilty in Federal Court (Westword)

  • Psilocybin Patents: Predictors and Drivers of Company Value? (Psilocybin Alpha)

MDMA

  • ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0” (Psymposia)

  • LGBTQIA Providers and Participants in MDMA Clinical Trials with Terence Ching (Chacruna)

DMT

  • Combatting resistant depression with DMT and digital therapy (Health Europa)

Ayahuasca

  • Dating My Ayahuasca Shaman: Sex, Power, and Consent (Chacruna)

  • Women’s Historical Influence on “Set and Setting” (Chacruna)

Iboga

  • In Defending Hunter, Biden Showed Us His Potential (Rolling Stone)

  • Why Ibogaine Is Not the Answer to the Opioid Crisis (Chacruna)

Synthetic Cannabinoids

Ketamine

  • Statement on Ketamine Sedation and Law Enforcement from the American College of Medical Toxicology (PR Web)

  • Study reveals how subanesthetic ketamine is effective in treating adult amblyopia (News-Medical.net)

  • A Dose of Ketamine Can Treat 'Lazy Eye' in Adults (Futurity)

Miscellaneous

  • Psychedelic Gold Rush? Psilocybin Startup Compass Pathways Goes Public at More than $1B (DoubleBlind)

  • Michigan Prosecutor Won’t Pursue Psychedelics Possession Cases Following Local Decriminalization Vote (Marijuana Moment)

  • Decriminalize Nature Promotes New Oakland Initiative While Condemning Fellow Activists (Lucid News)

  • Vermont Democratic Party Platform Calls For Decriminalizing Drugs And Legalizing Marijuana Sales (Marijuana Moment)

  • Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development (PR Newswire)

  • Psychedelics as a Catalyst for Existential Joy (Sam Woolfe)

  • ‘The Word of God in a Molecule’: Turning to Psychedelics During a Pandemic (Bedford + Bowery)

  • Did Early Christians Use Psychedelics? (The Daily Beast)

  • Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today (Psilocybin Alpha)

  • Psychedelic-Assisted Therapy in the Post-Pandemic Era (Psychedelic Science Review)

  • Psychedelic Industry 101: How to Get Involved (Reality Sandwich)

  • The Systemic Culture Problems of the Psychedelics Industry (Lucid News)

  • How I Used Psychedelics To Support My Sobriety (Yes, You Read That Right) (mindbodygreen)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.